DIVA Laboratories Ltd (4153) — Financial Flexibility Index
DIVA Laboratories Ltd (4153) has a Financial Flexibility Index of -0.03x as of March 2026. Free cash flow of NT$-14.49 Million (operating CF NT$-16.94 Million minus capex NT$2.45 Million) represents 0% of total liabilities (NT$447.40 Million). Check how aggressively does DIVA Laboratories Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
DIVA Laboratories Ltd Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for DIVA Laboratories Ltd across 9 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of DIVA Laboratories Ltd.
Annual Financial Flexibility Index for DIVA Laboratories Ltd (2017–2025)
Year-by-year free cash flow to debt coverage for DIVA Laboratories Ltd. Explore DIVA Laboratories Ltd (4153) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.07x | NT$21.77 Million | NT$20.77 Million | NT$324.52 Million | ▼ -86.6% |
| 2024 | 0.50x | NT$125.27 Million | NT$123.14 Million | NT$249.94 Million | ▼ -59.4% |
| 2023 | 1.24x | NT$260.60 Million | NT$252.91 Million | NT$210.93 Million | ▲ +244.1% |
| 2022 | 0.36x | NT$84.60 Million | NT$73.19 Million | NT$235.62 Million | ▲ +4702.4% |
| 2021 | 0.01x | NT$1.46 Million | NT$-11.39 Million | NT$195.27 Million | ▼ -81.8% |
| 2020 | 0.04x | NT$5.12 Million | NT$-16.64 Million | NT$124.34 Million | ▼ -89.4% |
| 2019 | 0.39x | NT$65.46 Million | NT$52.66 Million | NT$168.09 Million | ▼ -49.8% |
| 2018 | 0.78x | NT$107.73 Million | NT$86.02 Million | NT$138.87 Million | ▲ +261.0% |
| 2017 | 0.21x | NT$54.76 Million | NT$41.45 Million | NT$254.84 Million | — |